|
|
|
LH Description — Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings is a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. Co. reports its business in two segments, LabCorp Diagnostics (Dx) and Labcorp Drug Development (DD). Dx is an independent clinical laboratory business. Co. provides a menu of frequently requested primary testing and specialty testing through a network of primary and specialty laboratories across the U.S. DD provides end-to-end drug development, medical device and companion diagnostic development solutions from early-stage research to clinical development and commercial market access.
Company Name: |
Laboratory Corporation of America Holdings |
Website: |
www.labcorp.com |
Sector: |
Diagnostics |
Number of ETFs Holding LH: |
99 |
Total Market Value Held by ETFs: |
$2,717,620,327.25 |
Total Market Capitalization: |
$16,933,000,000 |
% of Market Cap. Held by ETFs: |
16.05% |
|
ETF |
LH Weight |
LH Amount |
VTI |
0.04% |
$531,675,659 |
VOO |
0.04% |
$429,798,513 |
VO |
0.23% |
$366,105,363 |
SPY |
0.04% |
$201,852,844 |
IVV |
0.04% |
$174,438,426 |
VTV |
0.09% |
$140,223,628 |
XLV |
0.33% |
$124,751,149 |
VOE |
0.43% |
$118,972,092 |
RSP |
0.19% |
$102,400,360 |
SPLV |
0.85% |
$60,673,371 |
List of all 99 ETFs holding LH
» |
|
|
|
|
Buy (3.43 out of 4)
100th percentile
|
PARTNER NEWS:Fri, Apr 19, 5:46 AM, Zacks
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are HCA, UHS, LH, EW, PODD.
Fri, Apr 19, 3:34 AM, Zacks
Labcorp (LH) Expected to Beat Earnings Estimates: Should You Buy? (Revised) Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
|
|